Suppression of Acute Herpetic Pain-Related Responses by the κ-Opioid Receptor Agonist (-)-17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-[N-methyl-3-trans-3-(3-furyl) Acrylamido] Morphinan Hydrochloride (TRK-820) in Mice
暂无分享,去创建一个
Hiroshi Nagase | Hiroshi Nojima | Ichiro Takasaki | I. Takasaki | H. Nojima | H. Nagase | Toshiaki Tanaka | Tomohiko Suzuki | Atsushi Sasaki | Kaoru Nakao | Mikito Hirakata | Kiyoshi Okano | Kimiyasu Shiraki | Yasushi Kuraishi | K. Shiraki | Tomohiko Suzuki | Y. Kuraishi | M. Hirakata | K. Nakao | Toshiaki Tanaka | A. Sasaki | Kiyoshi Okano | Mikito Hirakata
[1] P. Law,et al. Expression of mu-, delta-, and kappa-opioid receptor-like immunoreactivities in rat dorsal root ganglia after carrageenan-induced inflammation , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[2] J. Kamei,et al. Characterization of the antinociceptive effects of TRK-820 in the rat. , 2000, European journal of pharmacology.
[3] M. Satoh,et al. In situ hybridization study of μ- and κ-opioid receptor mRNAs in the rat spinal cord and dorsal root ganglia , 1994, Neuroscience Letters.
[4] C. Stevens,et al. Changes of opioid binding density in the rat spinal cord following unilateral dorsal rhizotomy , 1995, Brain Research.
[5] I. Takasaki,et al. Effects of Analgesics on Delayed Postherpetic Pain in Mice , 2002, Anesthesiology.
[6] M. Narita,et al. The novel kappa-opioid receptor agonist TRK-820 has no affect on the development of antinociceptive tolerance to morphine in mice. , 2000, European journal of pharmacology.
[7] R. Portenoy,et al. Acute herpetic and postherpetic neuralgia: Clinical review and current management , 1986, Annals of neurology.
[8] M. Narita,et al. Potent antinociceptive effects of TRK-820, a novel κ-opioid receptor agonist , 1999 .
[9] T. Masuda,et al. Expression of μ- and κ-, but not δ-, opioid receptor mRNAs is enhanced in the spinal dorsal horn of the arthritic rats , 1996, Pain.
[10] T. Yaksh,et al. Systemic and supraspinal, but not spinal, opiates suppress allodynia in a rat neuropathic pain model , 1995, Neuroscience Letters.
[11] M. Narita,et al. The novel kappa-opioid receptor agonist TRK-820 suppresses the rewarding and locomotor-enhancing effects of morphine in mice. , 2001, Life sciences.
[12] S. McCleary,et al. Enadoline, a selective κ-opioid receptor agonist shows potent antihyperalgesic and antiallodynic actions in a rat model of surgical pain , 1999, Pain.
[13] G. Guilbaud,et al. Antinociceptive effect of a kappa-opioid receptor agonist that minimally crosses the blood-brain barrier (ICI 204448) in a rat model of mononeuropathy. , 1995, European journal of pharmacology.
[14] I. Takasaki,et al. Allodynia and hyperalgesia induced by herpes simplex virus type-1 infection in mice , 2000, Pain.
[15] T. Nurmikko,et al. Clinical and Neurophysiological Observations on Acute Herpes Zoster , 1990, The Clinical journal of pain.
[16] J. Noguchi,et al. A novel method for counting spontaneous motor activity in the rat. , 1997, Brain research. Brain research protocols.
[17] M. Zimmermann,et al. Ethical guidelines for investigations of experimental pain in conscious animals , 1983, Pain.
[18] Xiao-jun Xu,et al. Treatment of chronic allodynia in spinally injured rats: effects of intrathecal selective opioid receptor agonists , 1998, Pain.
[19] T. Endoh,et al. Nor-binaltorphimine: a potent and selective kappa-opioid receptor antagonist with long-lasting activity in vivo. , 1992, Archives internationales de pharmacodynamie et de therapie.
[20] G. Catheline,et al. The antinociceptive activity of κ- but not δ-opioid receptor agonists is maintained in morphine-tolerant neuropathic rats , 1996 .
[21] R. Dworkin,et al. Pain and its persistence in herpes zoster , 1996, Pain.
[22] H. Nagase,et al. Pharmacological properties of TRK-820 on cloned μ-, δ- and κ-opioid receptors and nociceptin receptor , 1999 .
[23] H. Loh,et al. Association of kappa opioid receptor mRNA upregulation in dorsal root ganglia with mechanical allodynia in mice following nerve injury , 2000, Neuroscience Letters.
[24] J. Gnann. New antivirals with activity against varicella‐zoster virus , 1994, Annals of neurology.
[25] I. Takasaki,et al. Pharmacological and immunohistochemical characterization of a mouse model of acute herpetic pain. , 2000, Japanese journal of pharmacology.
[26] Xiao-jun Xu,et al. Reduced tolerance to the anti-hyperalgesic effect of methadone in comparison to morphine in a rat model of mononeuropathy , 2002, Pain.
[27] H. Nagase,et al. Discovery of a structurally novel opioid kappa-agonist derived from 4,5-epoxymorphinan. , 1998, Chemical & pharmaceutical bulletin.
[28] H. Mosberg,et al. kappa-Opioid receptor binding populations in rhesus monkey brain: relationship to an assay of thermal antinociception. , 1998, The Journal of pharmacology and experimental therapeutics.
[29] G. Catheline,et al. Lack of cross-tolerance between the antinociceptive effects of systemic morphine and asimadoline, a peripherally-selective κ-opioid agonist, in CCI-neuropathic rats , 1999, PAIN®.
[30] J. Loeser. Herpes zoster and postherpetic neuralgia , 1986, Pain.
[31] T. Lancaster,et al. Primary care management of acute herpes zoster: systematic review of evidence from randomized controlled trials. , 1995, The British journal of general practice : the journal of the Royal College of General Practitioners.
[32] Robert W. Johnson,et al. A Randomized Trial of Acyclovir for 7 Days or 21 Days with and without Prednisolone for Treatment of Acute Herpes Zoster , 1994 .
[33] I. Takasaki,et al. Gabapentin antinociception in mice with acute herpetic pain induced by herpes simplex virus infection. , 2001, The Journal of pharmacology and experimental therapeutics.
[34] E. Eliav,et al. The kappa opioid agonist GR89 696 blocks hyperalgesia and allodynia in rat models of peripheral neuritis and neuropathy , 1999, PAIN.